{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:58:26Z","timestamp":1792807106955,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015250","name":"NIHR Bristol Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jinf.2020.07.030","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:17:31Z","timestamp":1596194251000},"page":"521-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Route and duration of antibiotic therapy in acute cellulitis: A systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment"],"prefix":"10.1016","volume":"81","author":[{"given":"Elizabeth L.A.","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igho J.","family":"Onakpoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalie","family":"Shears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.A.","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Llewelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jinf.2020.07.030_bib0001","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0002","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: A Review","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jinf.2020.07.030_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206893","article-title":"Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012","volume":"13","author":"Tun","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2020.07.030_bib0004","article-title":"Hospital Episode Statistics","year":"2018","journal-title":"Admitted Patient Care"},{"key":"10.1016\/j.jinf.2020.07.030_bib0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12879-015-1071-0","article-title":"Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010","volume":"15","author":"Miller","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2020.07.030_bib0006","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv181","article-title":"Etiology of Cellulitis and Clinical Prediction of Streptococcal Disease: A Prospective Study","volume":"3","author":"Bruun","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2020.07.030_bib0007","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archinte.1986.00360140113016","article-title":"Microbiologic evaluation of cutaneous cellulitis in adults","volume":"146","author":"Hook","year":"1986","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0008","first-page":"370","article-title":"Does antibiotic restriction prevent resistance?","volume":"4","author":"McGowan","year":"1996","journal-title":"New Horiz"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2020.07.030_bib0009","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkg466","article-title":"Managing skin and soft tissue infections: expert panel recommendations on key decision points","volume":"52","author":"Eron","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MEJ.0000000000000245","article-title":"The management of cellulitis in emergency departments: Antibiotic-prescribing practices and adherence to practice guidelines in Ireland","volume":"23","author":"Quirke","year":"2016","journal-title":"Eur J Emerg Med"},{"issue":"10","key":"10.1016\/j.jinf.2020.07.030_bib0011","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/1469-0691.12632","article-title":"Pan-European early switch\/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections","volume":"20","author":"Nathwani","year":"2014","journal-title":"Clin Microbiol and Infec"},{"issue":"1","key":"10.1016\/j.jinf.2020.07.030_bib0012","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s12879-016-2067-0","article-title":"Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients","volume":"16","author":"Walsh","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2020.07.030_bib0013","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3947\/ic.2017.49.4.301","article-title":"Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection","volume":"49","author":"Kwak","year":"2017","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jinf.2020.07.030_bib0014","series-title":"Guidelines on the management of cellulitis in adults","year":"2005"},{"key":"10.1016\/j.jinf.2020.07.030_bib0015","series-title":"Summary of antimicrobial prescribing guidance - managing common infections","year":"2019"},{"key":"10.1016\/j.jinf.2020.07.030_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2019.0884","article-title":"Assessment of Antibiotic Treatment of Cellulitis and Erysipelas: A Systematic Review and Meta-analysis","author":"Brindle","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jinf.2020.07.030_bib0017","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jinf.2020.07.030_bib0018","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic","volume":"37","author":"Viera","year":"2005","journal-title":"Fam Med"},{"key":"10.1016\/j.jinf.2020.07.030_bib0019","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 8: Assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"issue":"4","key":"10.1016\/j.jinf.2020.07.030_bib0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jinf.2020.07.030_bib0021","series-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations","year":"2013"},{"key":"10.1016\/j.jinf.2020.07.030_bib0022","series-title":"[Computer program]. Version 5.3","year":"2014"},{"issue":"2","key":"10.1016\/j.jinf.2020.07.030_bib0023","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/dku397","article-title":"Oral versus parenteral antimicrobials for the treatment of cellulitis: a randomized non-inferiority trial","volume":"70","author":"Aboltins","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2020.07.030_bib0024","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.1992.tb08048.x","article-title":"Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study","volume":"127","author":"Bernard","year":"1992","journal-title":"Br J Dermatol"},{"issue":"7369","key":"10.1016\/j.jinf.2020.07.030_bib0025","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bmj.325.7369.864","article-title":"Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial","volume":"325","author":"Bernard","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2020.07.030_bib0026","doi-asserted-by":"crossref","DOI":"10.1097\/IPC.0000000000000146","article-title":"Oral Clindamycin Compared With Sequential Intravenous and Oral Flucloxacillin in the Treatment of Cellulitis in Adults","author":"Thomas","year":"2014","journal-title":"Infect Dis Clin Prac"},{"issue":"6","key":"10.1016\/j.jinf.2020.07.030_bib0027","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01645222","article-title":"The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas","volume":"12","author":"Jorup-Ronstrom","year":"1984","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.jinf.2020.07.030_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz335","article-title":"Lessons Learned From a Randomized Controlled Trial of Short-Course Intravenous Antibiotic Therapy for Erysipelas and Cellulitis of the Lower Limb (Switch Trial)","volume":"6","author":"Clarke","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2020.07.030_bib0029","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/030006059101900602","article-title":"Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group","volume":"19","author":"Daniel","year":"1991","journal-title":"J Int Med Res."},{"issue":"10","key":"10.1016\/j.jinf.2020.07.030_bib0030","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF01975848","article-title":"Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections","volume":"10","author":"Kiani","year":"1991","journal-title":"European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology"},{"issue":"15","key":"10.1016\/j.jinf.2020.07.030_bib0031","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.jinf.2020.07.030_bib0032","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jinf.2020.07.030_bib0033","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","article-title":"Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial","volume":"14","author":"Moran","year":"2014","journal-title":"The Lancet Infectious diseases"},{"issue":"7","key":"10.1016\/j.jinf.2020.07.030_bib0034","doi-asserted-by":"crossref","first-page":"e02218","DOI":"10.1128\/AAC.02252-18","article-title":"Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection","volume":"63","author":"Lv","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2020.07.030_bib0035","article-title":"Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomised, double-blind, placebo-controlled, non-inferiority trial","author":"Cranendonk","year":"2019","journal-title":"CMI"},{"issue":"Suppl E","key":"10.1016\/j.jinf.2020.07.030_bib0036","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/31.suppl_E.103","article-title":"A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections","volume":"31","author":"Rodriguez-Solares","year":"1993","journal-title":"J Antimicrob Chemother [Internet]"},{"issue":"Suppl C","key":"10.1016\/j.jinf.2020.07.030_bib0037","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/37.suppl_C.125","article-title":"A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and\/or soft tissue infections","volume":"37","author":"Montero","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2020.07.030_bib0038","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archinternmed.2011.29","article-title":"Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess","volume":"171","author":"Jenkins","year":"2011","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jinf.2020.07.030_bib0039","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jac\/dki092","article-title":"Nurse-led management of uncomplicated cellulitis in the community: Evaluation of a protocol incorporating intravenous ceftriaxone","volume":"55","author":"Seaton","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2020.07.030_bib0040","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s12325-013-0038-z","article-title":"Moxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study","volume":"30","author":"Bogner","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.jinf.2020.07.030_bib0041","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-2334-12-227","article-title":"A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes","volume":"12","author":"Lipsky","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2020.07.030_bib0042","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jinf.2005.02.017","article-title":"Lower limb cellulitis: features associated with length of hospital stay","volume":"52","author":"Morpeth","year":"2006","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.jinf.2020.07.030_bib0043","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archinte.167.7.709","article-title":"A predictive model of recurrent lower extremity cellulitis in a population-based cohort","volume":"167","author":"McNamara","year":"2007","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.jinf.2020.07.030_bib0044","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1440-1754.2007.01236.x","article-title":"Prospective evaluation of the management of moderate to severe cellulitis with parenteral antibiotics at a paediatric day treatment centre","volume":"44","author":"Gouin","year":"2008","journal-title":"J Paediatr Child Health"},{"issue":"12","key":"10.1016\/j.jinf.2020.07.030_bib0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/emermed-2017-206829","article-title":"Evaluating an admission avoidance pathway for children in the emergency department: Outpatient intravenous antibiotics for moderate\/severe cellulitis","volume":"34","author":"Ibrahim","year":"2017","journal-title":"Emerg Med J"},{"issue":"10","key":"10.1016\/j.jinf.2020.07.030_bib0046","doi-asserted-by":"crossref","first-page":"553","DOI":"10.5694\/j.1326-5377.1996.tb138641.x","article-title":"Case survey of management of cellulitis in a tertiary teaching hospital","volume":"165","author":"Aly","year":"1996","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0047","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PEC.0b013e3181d1de08","article-title":"Pediatric cellulitis: Success of emergency department short-course intravenous antibiotics","volume":"26","author":"Kam","year":"2010","journal-title":"Pediatr Emerg Care"},{"issue":"9","key":"10.1016\/j.jinf.2020.07.030_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204036","article-title":"Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment","volume":"13","author":"Collazos","year":"2018","journal-title":"PLoS One"},{"issue":"5 B","key":"10.1016\/j.jinf.2020.07.030_bib0049","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(85)90143-3","article-title":"Noncomparative trial of ticarcillin plus clavulanic acid in skin and soft tissue infections","volume":"79","author":"LeFrock","year":"1985","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10096-003-0902-x","article-title":"Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis","volume":"22","author":"Carratala","year":"2003","journal-title":"European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology"},{"issue":"9","key":"10.1016\/j.jinf.2020.07.030_bib0051","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00228-012-1240-7","article-title":"Variability of antimicrobial prescribing in patients with acute cellulitis","volume":"68","author":"Davies","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jinf.2020.07.030_bib0052","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jinf.2010.03.014","article-title":"Risk stratification and outcome of cellulitis admitted to hospital","volume":"60","author":"Figtree","year":"2010","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.jinf.2020.07.030_bib0053","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/656431","article-title":"Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship","volume":"51","author":"Jenkins","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2020.07.030_bib0054","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2004.12.010","article-title":"Erysipelas and cellulitis: Clinical and microbiological spectrum in an Italian tertiary care hospital","volume":"51","author":"Lazzarini","year":"2005","journal-title":"J Infect"},{"issue":"311","key":"10.1016\/j.jinf.2020.07.030_bib0055","article-title":"Clinical and microbiological characteristics of purulent and non-purulent cellulitis in hospitalized Taiwanese adults in the era of community-associated methicillin-resistant Staphylococcus aureus","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0056","first-page":"137","article-title":"Corticosteroid therapy in combination with antibiotics for erysipelas","volume":"20","author":"Solomon","year":"2018","journal-title":"Isr Med Assoc J"},{"issue":"11","key":"10.1016\/j.jinf.2020.07.030_bib0057","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1017\/ice.2019.253","article-title":"Evaluation of a multifaceted approach to antimicrobial stewardship education methods for medical residents","volume":"40","author":"Vanlangen","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"10.1016\/j.jinf.2020.07.030_bib0058","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/INF.0000000000000304","article-title":"Clinical characteristics and antibiotic utilization in pediatric patients hospitalized with acute bacterial skin and skin structure infection","volume":"33","author":"Moore","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.jinf.2020.07.030_bib0059","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5694\/j.1326-5377.1998.tb123398.x","article-title":"Home-based treatment of cellulitis with twice-daily cefazolin","volume":"169","author":"Leder","year":"1998","journal-title":"Med J Aust"},{"key":"10.1016\/j.jinf.2020.07.030_bib0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/IJGM.S230054","article-title":"Out Of Hospital And In Hospital Management Of Cellulitis Requiring Intravenous Therapy","volume":"12","author":"Ong","year":"2019","journal-title":"Int J Gen Med"},{"issue":"12","key":"10.1016\/j.jinf.2020.07.030_bib0061","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/SMJ.0b013e3182387365","article-title":"Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid","volume":"104","author":"Bader","year":"2011","journal-title":"South Med J"},{"key":"10.1016\/j.jinf.2020.07.030_bib0062","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12879-017-2569-4","article-title":"Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore","volume":"17","author":"Chan","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2020.07.030_bib0063","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/emj.2004.018143","article-title":"Emergency department management of home intravenous antibiotic therapy for cellulitis","volume":"22","author":"Donald","year":"2005","journal-title":"Emergency medicine journal: EMJ"},{"issue":"12","key":"10.1016\/j.jinf.2020.07.030_bib0064","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.amjmed.2013.08.016","article-title":"Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting","volume":"126","author":"Hurley","year":"2013","journal-title":"Am J Med"},{"issue":"Supplement 2","key":"10.1016\/j.jinf.2020.07.030_bib0065","first-page":"129","article-title":"Continuous cefazolin infusion versus cefazolin plus probenecid for the ambulatory treatment of uncomplicated cellulitis: A retrospective cohort study","volume":"28","author":"Landry","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0066","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10096-009-0855-9","article-title":"Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting","volume":"29","author":"Lillie","year":"2010","journal-title":"European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology"},{"issue":"7","key":"10.1016\/j.jinf.2020.07.030_bib0067","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ajem.2016.04.022","article-title":"Intravenous Home Infusion Therapy Instituted from a 24-Hour Clinical Decision Unit for Patients with Cellulitis","volume":"34","author":"Rentala","year":"2016","journal-title":"Am J Emerg Med"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0068","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/INF.0000000000000992","article-title":"Who can have parenteral antibiotics at home? A prospective observational study in children with moderate\/severe cellulitis","volume":"35","author":"Ibrahim","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.jinf.2020.07.030_bib0069","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10096-016-2631-y","article-title":"OPAT for cellulitis: its benefits and the factors that predispose to longer treatment","volume":"35","author":"Zhang","year":"2016","journal-title":"European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology"},{"issue":"5","key":"10.1016\/j.jinf.2020.07.030_bib0070","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/bjd.16235","article-title":"Which outcomes are reported in cellulitis trials? Results of a review of outcomes included in cellulitis trials and a patient priority setting survey","volume":"178","author":"Smith","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jinf.2020.07.030_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2012.03.024","article-title":"Lower limb cellulitis and its mimics: part I. Lower limb cellulitis","volume":"67","author":"Hirschmann","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jinf.2020.07.030_bib0072","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2133.2011.10275.x","article-title":"Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care","volume":"164","author":"Levell","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jinf.2020.07.030_bib0073","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamadermatol.2016.3816","article-title":"Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis","volume":"153","author":"Weng","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jinf.2020.07.030_bib0074","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cmi.2018.11.002","article-title":"The quality of studies evaluating antimicrobial stewardship interventions: a systematic review","volume":"25","author":"Schweitzer","year":"2019","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"10.1016\/j.jinf.2020.07.030_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12874-018-0618-3","article-title":"Likelihood-based random-effects meta-analysis with few studies: empirical and simulation studies","volume":"19","author":"Seide","year":"2019","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.jinf.2020.07.030_bib0076","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/ije\/dym018","article-title":"Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography","volume":"36","author":"Sanderson","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"3993","key":"10.1016\/j.jinf.2020.07.030_bib0077","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.2.3993.101","article-title":"Prontosil in Erysipelas: a controlled series of 312 cases","volume":"2","author":"Snodgrass","year":"1937","journal-title":"Bmj"},{"issue":"4014","key":"10.1016\/j.jinf.2020.07.030_bib0078","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/bmj.2.4014.1156","article-title":"Sulphanilamide in the Treatment of Erysipelas","volume":"2","author":"Snodgrass","year":"1937","journal-title":"Br Med J"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320305120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320305120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:29:44Z","timestamp":1759008584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320305120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0163445320305120"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.07.030","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Route and duration of antibiotic therapy in acute cellulitis: A systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}